VSEE HEALTH INC

VSee Health plans an 80‑for‑1 reverse split to boost share value, curb dilution and strengthen its telehealth balance sheet, aiming to stay Nasdaq‑listed.

VSee Health’s new convertible notes boost liquidity and growth, showing how the digital‑health firm secures capital while protecting shareholders.

VSee Health’s June 26 2026 prospectus supplement reveals a critical capital‑raise amid looming debt default, with shares sold, market price plummeting, and investors watching closely.

VSee Health Inc.’s 2025 annual report reveals how its VSee Lab platform, low‑code telehealth solutions, and strategic partnerships drive growth amid fierce competition, demand swings, and market volatility.

VSee Health Inc. secures a $6 M private investment to fuel expansion, while its volatility and negative P/E hint at growth potential amid strategic acquisition plans.

VSee Health Inc, a healthcare company listed on the Nasdaq, has a market capitalization of $9.9 million and has experienced significant stock price fluctuations over the past year.

VSee Health Inc. is a digital health company navigating financial volatility and strategic acquisitions, positioning itself for growth and innovation in the rapidly evolving health care sector.

VSee Health Inc’s stock price has experienced a dramatic rollercoaster ride, with significant fluctuations and a current market capitalization of $17.2 million, raising questions about its future in the digital health sector.